These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34546514)

  • 21. [Comparison of 1-year outcomes between Roux-en-Y gastric bypass and sleeve gastrectomy with Roux-en-Y duodenojejunal bypass in the patients of obesity with type 2 diabetes mellitus].
    Liang H; Si YM; Lin SB; Shen JJ; Guan W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Nov; 26(11):1051-1057. PubMed ID: 37974350
    [No Abstract]   [Full Text] [Related]  

  • 22. Two-year outcomes of Roux-en-Y gastric bypass vs medical treatment in type 2 diabetes with a body mass index lower than 32.5 kg/m
    Ling J; Tang H; Meng H; Wu L; Zhu L; Zhu S
    J Endocrinol Invest; 2022 Sep; 45(9):1729-1740. PubMed ID: 35596918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    Aminian A; Al-Kurd A; Wilson R; Bena J; Fayazzadeh H; Singh T; Albaugh VL; Shariff FU; Rodriguez NA; Jin J; Brethauer SA; Dasarathy S; Alkhouri N; Schauer PR; McCullough AJ; Nissen SE
    JAMA; 2021 Nov; 326(20):2031-2042. PubMed ID: 34762106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of NASH with Gastric Bypass.
    Jirapinyo P; Thompson CC
    Curr Gastroenterol Rep; 2018 Sep; 20(10):49. PubMed ID: 30244334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric bypass specifically impairs liver parameters as compared with sleeve gastrectomy, independently of evolution of metabolic disorders.
    Ledoux S; Sami O; Calabrese D; Le Gall M; Flamant M; Coupaye M
    Surg Obes Relat Dis; 2019 Feb; 15(2):220-226. PubMed ID: 30598254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant PPARα and FXR Activation as a Putative Mechanism of NASH Improvement after Gastric Bypass Surgery: a GEO Datasets Analysis.
    Mazzini GS; Khoraki J; Dozmorov M; Browning MG; Wijesinghe D; Wolfe L; Gurski RR; Campos GM
    J Gastrointest Surg; 2019 Jan; 23(1):51-57. PubMed ID: 30206765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACCURACY OF ELASTOGRAPHY IN THE ASSESSMENT OF REDUCTION IN LIVER STEATOSIS AND FIBROSIS IN THE EARLY POSTOPERATIVE PERIOD AFTER BARIATRIC SURGERY.
    Lima RR; Garcia JHP; Studart MS; Pinheiro FS; Pinto JOG; Sales LA; Soares LM; Santos PA
    Arq Bras Cir Dig; 2022; 35():e1671. PubMed ID: 36043649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propensity score matching analysis comparing outcomes between primary and revision Roux-en-Y gastric bypass after adjustable gastric banding: a retrospective record-based cohort study.
    Hany M; Sayed IE; Zidan A; Ibrahim M; Agayby ASS; Torensma B
    Surg Endosc; 2023 Feb; 37(2):1303-1315. PubMed ID: 36197519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-Term Outcomes of Sleeve Gastrectomy plus Jejunojejunal Bypass: a Retrospective Comparative Study with Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Chinese Patients with BMI ≥ 35 kg/m
    Lin S; Guan W; Yang N; Zang Y; Liu R; Liang H
    Obes Surg; 2019 Apr; 29(4):1352-1359. PubMed ID: 30635811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One anastomosis gastric bypass versus Roux-en-Y gastric bypass: a 30-day follow-up review.
    Docimo S; Yang J; Zhang X; Pryor A; Spaniolas K
    Surg Endosc; 2022 Jan; 36(1):498-503. PubMed ID: 33591446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robotic platform for gastric bypass is associated with more resource utilization: an analysis of MBSAQIP dataset.
    Sharma G; Strong AT; Tu C; Brethauer SA; Schauer PR; Aminian A
    Surg Obes Relat Dis; 2018 Mar; 14(3):304-310. PubMed ID: 29276076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic sleeve gastrectomy to Roux-en-Y gastric bypass conversion versus primary Roux-en-Y gastric bypass: a propensity score matching analysis.
    O'Laughlin M; Cornejo J; Zevallos A; Coker A; Schweitzer M; Adrales G; Li C; Sebastian R
    Surg Endosc; 2023 Oct; 37(10):7947-7954. PubMed ID: 37433912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Banded Roux-en-Y gastric bypass in patients with super morbid obesity (BRandY-study): protocol of a cohort study with 10 year follow-up.
    Romeijn MM; Leclercq WKG; Luijten AAPM; Janssen L; van Dielen FMH
    BMC Surg; 2020 Jun; 20(1):122. PubMed ID: 32503510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.
    Billeter AT; Senft J; Gotthardt D; Knefeli P; Nickel F; Schulte T; Fischer L; Nawroth PP; Büchler MW; Müller-Stich BP
    Obes Surg; 2016 Aug; 26(8):1867-74. PubMed ID: 26660688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of sleeve gastrectomy and Roux-en-Y gastric bypass after failure of gastric banding: a two-center study with a propensity score-matched analysis.
    Vallois A; Rebibo L; Le Roux Y; Dhahri A; Alves A; Regimbeau JM
    Surg Endosc; 2021 Jul; 35(7):3513-3522. PubMed ID: 32851467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trajectory of NAFLD characteristics after Roux-en-Y gastric bypass: a five-year historical cohort study.
    Kreve F; Callejas GH; Jimenez LS; Marques RA; Chaim FDM; Utrini MP; Gestic MA; Ramos AC; Chaim EA; Cazzo E
    Sao Paulo Med J; 2022; 140(6):739-746. PubMed ID: 36102453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric band conversion to Roux-en-Y gastric bypass shows greater weight loss than conversion to sleeve gastrectomy: 5-year outcomes.
    Creange C; Jenkins M; Pergamo M; Fielding G; Ren-Fielding C; Schwack B
    Surg Obes Relat Dis; 2018 Oct; 14(10):1531-1536. PubMed ID: 30449510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omega-loop gastric bypass is more effective for weight loss but negatively impacts liver enzymes: a registry-based comprehensive first-year analysis.
    Spivak H; Munz Y; Rubin M; Raz I; Shohat T; Blumenfeld O
    Surg Obes Relat Dis; 2018 Feb; 14(2):175-180. PubMed ID: 29217131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis.
    Poljo A; Kopf S; Sulaj A; Roessler S; Albrecht T; Goeppert B; Bojko S; Müller-Stich BP; Billeter AT
    Surg Obes Relat Dis; 2023 Dec; 19(12):1421-1434. PubMed ID: 37666725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
    Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
    BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.